Coatue Management LLC Bio N Tech Se Transaction History

Coatue Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $23.3 Million - $36.6 Million	196,641 Added 46.64%	618,231 $92.9 Million
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $80.3 Million - $147 Million	-636,071 Reduced 60.14%	421,590 $71.9 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $5.13 Million - $8.58 Million	23,676 Added 2.29%	1,057,661 $273 Million
Q3 2021 Nov 12, 2021	SELL	$205.93 - $447.23 $41.7 Million - $90.5 Million	-202,332 Reduced 16.37%	1,033,985 $282 Million
Q2 2021 Aug 13, 2021	BUY	$113.32 - $241.49 $101 Million - $216 Million	894,471 Added 261.66%	1,236,317 $277 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $29.3 Million - $40.9 Million	341,846 New	341,846 $37.3 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Coatue Management LLC, based on Form 13F filings with the SEC.

Stay updated on Coatue Management LLC with notifications on news.